Back to search

Article

Early Neuroinflammatory Signatures and Glucagon-Like Peptide 1 Levels in Neuropathic Symptoms: Evidence from Newly Diagnosed Type 2 Diabetes Mellitus

2026-04-29

Abstract excerpt

<title>Abstract</title> <p>Aim Neuropathic symptoms are among the earliest neurological manifestations of type 2 diabetes mellitus (T2DM) and may precede electrophysiologically confirmed diabetic sensorimotor polyneuropathy (DSPN). The underlying mechanisms in treatment-naïve individuals remain incompletely understood. This study investigated the associations of serum glucagon-like peptide-1 (GLP-1), tumor necro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
219e9371-4335-5afb-9460-51da7c044ff4
DOI
10.21203/rs.3.rs-9149051/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Early Neuroinflammatory Signatures and Glucagon-Like Peptide 1 Levels in Neuropathic Symptoms: Evidence from Newly Diagnosed Type 2 Diabetes MellitusDOI 10.21203/rs.3.rs-9149051/v1
Select a neighboring publication to make it the new centre.